The meta-analysis of active IBD vs. healthy controls showed significantly higher levels of resistin in patients with active IBD (SMD 1.40, 95% CI 0.50 to 2.30, p-value = 0.002, Fig. 5B). Here, RETN is linked to inflammatory bowel disease.